Bio-insecurity and HIV/AIDS
Science and global funding of HIV prevention is seen as an investment in biosecurity, but unless prevention and treatment take place within the context of the local bio-insecurity of the poor woman and her family the AIDS epidemic can not be fully stemmed, argue Ida Susser and Zena Stein
The right to know: women’s choices, Depo-Provera and HIV
As we enter the fourth decade of AIDS, we need to assert once again the importance of transparency, knowledge and autonomy in the introduction and distribution of technologies for prevention and treatment of the disease.
HIV: the fight for trade related intellectual property regulations
We need to fight the narrowing opportunities for the production of generic AIDS and other drugs. As India is conforming to new patent laws, more people are contracting HIV
A microbicide success: feminism is essential to good science
Advocates for women pushed for microbicides when scientists working on AIDS vaccines and treatment had not even envisioned the problem of “methods women can use.” The announcement of the first microbicide ever shown to prevent HIV in women is the product of feminist visions